Skip to content

Study · Randomized controlled trial · n = 43 · 1993

1 result

Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder.

Pitman RK, Orr SP, Lasko NB

Psychiatry research1 Aug 1993Cited by 106 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In Vietnam veterans with PTSD, physiologic responding during combat imagery followed the order vasopressin > placebo > oxytocin, so it was lowest after intranasal oxytocin 20 IU.

    In plain wordsIn veterans with PTSD, body stress responses to combat imagery were lowest after oxytocin, below placebo; the abstract reports only the group order.

    Peptide
    Oxytocin
    Outcome
    DecreasePhysiologic responding (heart rate, skin conductance, EMG) during combat imagery
    Study

    n = 43

    Comparator
    Placebo
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    20 IU · intranasalAs given in this study (human).

    Source sentences

    Summary
    The group order of physiologic responding was as predicted: vasopressin > placebo > oxytocin.
    2 context sentences
    Summary · context
    This study measured heart rate, skin conductance, and lateral frontalis electromyographic (EMG) responses in 43 male Vietnam veterans with posttraumatic stress disorder during personal combat imagery.
    Summary · context
    In a double-blind research design, subjects were randomly assigned to receive intranasal arginine vasopressin (20 IU), placebo, or oxytocin (20 IU) an hour before the experiment.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.